Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-10-11
1993-02-16
Nutter, Nathan M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514306, A01N 4348, A61K 31165
Patent
active
051871670
ABSTRACT:
A quinazoline of the formula:- ##STR1## wherein R.sup.1 is alkyl, cycloalkyl, alkenyl, alkynyl, alkoxy, alkylthio, aryl, aryloxy, arylalkyl, halogeno, hydroxy, mercapto, pyridylthio, pyrimidinylthio, or substituted alkyl or alkoxy;
wherein R.sup.2 is hydrogen, alkyl, alkenyl, alkynyl, substituted alkyl or alkanoyl;
wherein Ar is phenylene, naphthylene or heterocyclene which is unsubstituted or bears one or more substituents and wherein R.sup.3 is such that R.sup.3 --NH.sub.2 is an amino acid; or a pharmaceutically-acceptable salt or ester thereof. The compounds possess anti-tumor activity.
REFERENCES:
patent: 4564616 (1986-01-01), Jones et al.
Jones et al. in "Anticancer Quinazoline-Substituted Amino Acids", CA 106(13) 102,679c, May, 1986.
Culpeper Mullis Jeffrey
Imperial Chemical Industries plc
Nutter Nathan M.
LandOfFree
Pharmaceutical compositions comprising quinazolin-4-one derivati does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions comprising quinazolin-4-one derivati, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions comprising quinazolin-4-one derivati will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2148175